Mindstrong Stock
Digital Mental Healthcare
Sign up today and learn more about Mindstrong Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Mindstrong Stock
Mindstrong's patented science and technology was developed by Dr. Dagum, and is based on four years of extensive clinical studies applying machine intelligence to human-computer interactions patterns. Dr. Dagum's work creates, for the first time, a way to objectively and continuously measure brain function day-to-day providing new insight not previously possible with traditional neuropsychological and imaging techniques. Mindstrong products are in clinical trials in numerous partnership projects with payers, providers, academics and the pharmaceutical industry to bring these new tools to bear on answering the most fundamental questions in behavioral health.
Investors
General Catalyst Partners
Snap, Jet, Stripe, Relativity Space, Devoted Health, Lacework, Oscar Health, Circle, Hopin, Vroom
8VC
Anduril Industries, Sila Nanotechnologies, Cityblock Health, project44, Blend, Aspiration, Addepar, Illumio, BlueVoyant, Guardant Health
Berggruen Holdings
Foresite Capital
EverlyWell, Crossover Health, Aetion, Genapsys, Mindstrong, DNAnexus
One Mind Brain Health Impact Fund
Funding History
June 2017 | $14.0M |
---|---|
June 2018 | $15.0M |
December 2018 | $31.0M |
May 2020 | $100M |
Management
Chief Executive Officer
Michelle Wagner
Chief Technology Officer
Miguel Alvarado
Press
wealthbriefing - Jun, 8 2021
How Family Offices Can Join The Health Tech Revolutionmobihealthnews - Oct, 9 2020
Livongo's lead investor on what the next model of care could look likehealthtechpulse - Jun, 9 2020
COVID-19 accelerates healthtech adoptionventure-med - Jun, 2 2020
Mindstrong Bag $100m Investment, Plans to Scale Its Offeringbit - May, 23 2020
Mindstrong scores $100M to monitor wellness via smartphone behaviors